Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2019 Earnings Conference Call Transcript
Feb 11, 2019 • 04:30 pm ET
Good afternoon, and welcome to the Aethlon Medical's Third Quarter Fiscal 2019 Earnings and Corporate Update Conference Call. All participants will be in a listen-only mode. (Operator Instructions) After today's presentation there will be an opportunity to ask questions. (Operator Instructions) Please also note, today's event is being recorded.
At this time, I'd like to turn the conference call over to Mr. Jim Frakes, Chief Financial Officer. Sir, please go ahead.
James B. Frakes
Thank you, operator, and good afternoon everyone. Welcome to Aethlon Medical's third quarter fiscal year 2019 conference call. My name is Jim Frakes and I'm Aethlon's Chief Financial Officer. At 4:15 PM Eastern Time today Aethlon Medical released financial results for its third quarter ended December 31, 2018. If you have not seen or received Aethlon Medical's earnings release please visit the Investors page at www.aethlonmedical.com.
Following this introduction, and the reading of our forward-looking statements, Aethlon's Chairman Dr. Charles Fisher and our CEO, Dr. Tim Rodell, will provide an overview of Aethlon's strategy and recent developments. I will then make some brief remarks on Aethlon's financials. We will then open up the call for the Q&A session.
Before I hand the call over to Dr. Fisher, please note that the news release today and this call contain forward-looking statements within the meaning of the Federal Securities Act of 1933 and the Securities Exchange Act of 1934. The company cautions you that any statement that is not a statement of historical fact is a forward-looking statement. These statements are based on expectations and assumptions as of the date of this conference call. Such forward-looking statements are subject to significant risks and uncertainties, and actual results may differ materially from the results anticipated in the forward-looking statements. Factors that could cause results to differ materially from those anticipated in forward-looking statements can be found under the caption Risk Factors in the company's Annual Report on Form 10-K for the fiscal year ended March 31, 2018 and in the company's other filings with the Securities and Exchange Commission. Except as maybe required by law, the company does not intend, nor does it undertake any duty to update this information to reflect future events or circumstances.
With that I will now turn the call over to Dr. Charles Fisher, Aethlon Medical's, Chairman.
Charles J. Fisher
Good afternoon, everyone. It's my pleasure to join in this call today as the Chairman of Aethlon Medical Inc., and introduce my colleague Tim Rodell. In the past year as Chairman, since I was elected such, we have done some revisions to our Board to help strengthen it in different positions, and we're very pleased with where we are. And most recently, we are very pleased that we have been able to attract Dr. Timothy Rodell, to be the Interim CEO here at Aethlon Medical. I've had the pleasure and privilege of knowing and working with Tim over the past 30 years. He's been CEOs of both public and private companies. He has been a thought leader in a number of